Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POLYbio: MTX-PG Concentration in Rheumatoid Arthritis
NCT04470453Phase 4Terminated
- Sponsor
- CHU Saint-Etienne
- Start
- Oct 2020
- Primary completion
- Apr 2024
- Countries
- 1
01
Overview
Phase 4, open-label trial (2 arms), sponsored by CHU Saint-Etienne. Primary endpoint: Erythrocyte Methotrexate Polyglutamate Concentration. Started Oct 2020; status: terminated.
Beyond the preview
Go deeper on NCT04470453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04470453.